Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

DRTS stock hub

Alpha Tau Medical Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

DRTSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
749M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
DRTS
In the news

Latest news · DRTS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-61
P25 -105.6P50 -46.5P75 -3.1
ROIC-31.8
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All DRTS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001871321
Company name
Alpha Tau Medical Ltd.
Country
Israel
Country code
US
Cusip
M0740A108
Employees
121
Employees Change
-4%
Employees Change Percent
-3.2
Enterprise value
$689.6M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
IL0011839383
Last refreshed
2026-05-10
Market cap
$749M
Market cap category
Small-Cap
Price
$8.51
Price currency
USD
Sector
Healthcare
Sic
3841
Symbol
DRTS
Website
https://www.alphatau.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-5.69%
EV Sales Forward
737.51x
FCF yield
-4.37%
P/B ratio
9.71x
PS Forward
801.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-42.6M
Net Income Growth Years
0%
Profit Per Employee
$-352,289
ROA
-27.55
Roa5y
-22.65
ROCE
-44.45
ROE
-61
Roe5y
-48.67
ROIC
-31.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
213.11%
Cagr3y
42.18%
Cagr5y
-2.6%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
$105.7M
Cash
$73.1M
Current Assets
$78.3M
Current Liabilities
$10.5M
Debt
$13.7M
Debt Equity
$0.18
Equity
$77.1M
Interest Coverage
-121.9
Liabilities
$28.6M
Long Term Assets
$27.4M
Long Term Liabilities
$18M
Net Cash
$59.4M
Net Cash By Market Cap
$7.93
Net Cash Growth
26.21%
Net Debt Equity
$-0.77
Tangible Book Value
$77.1M
Tangible Book Value Per Share
$0.88
WACC
10.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
7.45
Net Working Capital
$-4.2M
Quick ratio
6.99
Working Capital
$67.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-15.24%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
212.87%
200-day SMA
5.38
3Y total return
187.5%
50-day SMA
7.41
50-day SMA vs 200-day SMA
50over200
5Y total return
-12.36%
All Time High
20.65
All Time High Change
-58.79%
All Time High Date
2022-03-24
All Time Low
1.75
All Time Low Change
386.29%
All Time Low Date
2024-06-27
ATR
0.59
Beta
1.12
Beta1y
1.1
Beta2y
0.9
Ch YTD
71.92
High
8.59
High52
9.07
High52 Date
2026-05-04
High52ch
-6.18%
Low
7.7
Low52
2.57
Low52 Date
2025-05-09
Low52ch
231.13%
Ma50ch
14.91%
Premarket Change Percent
-0.51
Premarket Price
$7.81
Premarket Volume
6,799
Price vs 200-day SMA
58.24%
RSI
60.21
RSI Monthly
72.9
RSI Weekly
72.16
Sharpe ratio
1.96x
Sortino ratio
3.44
Total Return
-15.24%
Tr YTD
71.92
Tr1m
19.19%
Tr1w
-0.35%
Tr3m
19.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

7
MetricValue
Analyst Count
3
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.12
Earnings Revenue Estimate
113,600x
Operating Income
$-42.3M
Price target
$8.67
Price Target Change
$1.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
45,316,218%
Float Percent
51.49%
Shares Insiders
16.19%
Shares Institutions
3.14%
Shares Out
88,009,737
Shares Qo Q
1.06%
Shares Yo Y
15.24%
Short Float
2.01%
Short Ratio
3.83
Short Shares
1.03

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-43.4M
Average Volume
476,902.95x
Bv Per Share
0.88
CAPEX
$-6.1M
Ch1m
19.19
Ch1w
-0.35
Ch1y
212.9
Ch3m
19.69
Ch3y
187.5
Ch5y
-12.36
Ch6m
120.5
Change
8.41%
Change From Open
8.82
Close
7.85
Days Gap
-0.38
Depreciation Amortization
1,232,000
Dollar Volume
4,194,306.7
Earnings Date
2026-05-19
Earnings Time
amc
EBIT
$-42.3M
EBITDA
$-41.1M
EPS
$-0.53
F Score
2
FCF
$-32.8M
FCF EV Yield
-4.75x
FCF Per Share
$-0.37
Financing CF
45,768,000
Fiscal Year End
December
Founded
2,015
Income Tax
$121,000
Investing CF
-20,588,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-09
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-09
Ma150
5.99
Ma150ch
41.98%
Ma20
7.89
Ma20ch
7.83%
Net CF
-1,522,000
Next Earnings Date
2026-05-22
Open
7.82
Optionable
Yes
Position In Range
91.01
Post Close
8.51
Postmarket Change Percent
1.41
Postmarket Price
$8.63
Ppne
26,875,000
Pre Close
7.85
Price Date
2026-05-08
Ptbv Ratio
9.71
Relative Volume
1.03x
Share Based Comp
10,617,000
Tr6m
120.47%
Volume
492,868
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does DRTS pay a dividend?

Capital-return profile for this ticker.

Performance

DRTS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+212.9%
S&P 500 1Y: n/a
3Y total return
+187.5%
S&P 500 3Y: n/a
5Y total return
-12.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns DRTS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.1%
Float: +51.5% of shares outstanding
Insider ownership
+16.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+2.0%
3.8 days to cover
Y/Y dilution
+15.2%
Negative means the company is buying back shares.
Technical

DRTS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.2
Neutral momentum band
Price vs 200-day MA
+58.2%
50/200-day relationship not available
Beta (5Y)
1.12
Moves roughly with the market
Sharpe ratio
1.96
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About DRTS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DRTS stock rating?

Alpha Tau Medical Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DRTS analysis?

The full report lives at /stocks/DRTS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DRTS?

The latest report frames DRTS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DRTS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.